Mylan signs U.S. license deal on Humira with AbbVie
July 17, 2018 at 08:46 AM EDT
AbbVie Inc said on Tuesday it signed a U.S. licensing deal with Mylan NV for its proposed biosimilar to AbbVie's blockbuster drug Humira, in a move that will give it more near-term control over the competition.
